Patent · US Expired

B-homoestra-1,3,5(10)-trienes as modulators of tubulin polymerization

US6696436B1 · kind B1 · utility

0Cited by
4References
39Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 16, 2002
Grant dateFeb 24, 2004
Priority date
Expiry dateAug 16, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J63/004
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention provides B-ring expanded estra-1,3,5(10)-triene compounds of general formula (1) which modulate the polymerization of tubulin and/or the depolymerization of microtubules. The compounds have anti-angiogenic and anti-tumor activity. The invention also provides methods of preparing the compounds, and methods of using the compounds for the treatment of cancer or other mammalian diseases characterized by undesirable angiogenesis. The compounds of the invention are also expected to have utility as research tools.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.